lipopolysaccharides

Preferred Label : lipopolysaccharides;

MeSH definition : Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed);

MeSH synonym : lipoglycans; Lipopolysaccharide;

MeSH annotation : coordinate IM with specific bacterium (IM) if pertinent; DF: LPS; oordinate with specific bacterium if pertinent;

Wikipedia link : https://en.wikipedia.org/wiki/Lipopolysaccharide;

Is substance : O;

Details

Origin ID

D008070;

UMLS CUI

C0023810;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Lipopolysaccharide [NCIt concept]
- Lipopolysaccharide [FMA entity]
- Lipopolysaccharide (substance) [SNOMED CT concept]
- lipopolysaccharide, nos [SNOMED Notion]
- lipopolysaccharides [IUPAC Term]
Indexing information
- 5,7-diacetamido-8-O-acetyl-3,5,7,9-tetradeoxy-glycero-talo-nonulosonic acid [MeSH Supplementary Concept]
- Atf3 protein, mouse [MeSH Supplementary Concept]
- E5564 [MeSH Supplementary Concept]
- EOLA1 protein, human [MeSH Supplementary Concept]
- LRBA protein, human [MeSH Supplementary Concept]
- SAEP-2 peptide [MeSH Supplementary Concept]
- SAEP-4 peptide [MeSH Supplementary Concept]
- allyl 6-O-(3-deoxyoct-2-ulopyranosylonic acid)-(1-6)-2-deoxy-2-(3-hydroxytetradecanamido)glucopyranoside 4-phosphate [MeSH Supplementary Concept]
- alphaKdo(2-4)alphaKdo(2-4)alphaKdo(Kdo, 3-deoxy-D-manno-oct-2-ulopyranosonic acid) [MeSH Supplementary Concept]
- core endotoxin [MeSH Supplementary Concept]
- endotoxin, Escherichia coli [MeSH Supplementary Concept]
- heptadepsin, paenibacillus [MeSH Supplementary Concept]
- lipopolysaccharide-binding protein [MeSH Supplementary Concept]
- lrba protein, mouse [MeSH Supplementary Concept]
Record concept(s)
- lipopolysaccharides [MeSH concept]
Related MeSH Supplementary Concept(s)
- 2-(4-azidosalicylamido)-1,3'-dithiopropionate-lipopolysaccharide [MeSH Supplementary Concept]
- 4-hydroxy-2,6-dimethoxyphenyl-6'-O-syringoyl-beta-D-glucopyranoside [MeSH Supplementary Concept]
- 4-hydroxy-2,6-dimethoxyphenyl-6'-O-vanilloyl-beta-D-glucopyranoside [MeSH Supplementary Concept]
- A antigen (Brucella abortus) [MeSH Supplementary Concept]
- AFCo3 cochleate [MeSH Supplementary Concept]
- B 1287 [MeSH Supplementary Concept]
- BCG lipopolysaccharide [MeSH Supplementary Concept]
- CE3 lipopolysaccharide [MeSH Supplementary Concept]
- CIA07 adjuvant [MeSH Supplementary Concept]
- EF-RAG [MeSH Supplementary Concept]
- F62 lipooligosaccharide [MeSH Supplementary Concept]
- FEV1 lipopolysaccharide [MeSH Supplementary Concept]
- J-5 lipopolysaccharide [MeSH Supplementary Concept]
- K-12 lipopolysaccharide [MeSH Supplementary Concept]
- Kdo2-lipid A [MeSH Supplementary Concept]
- NP000778 [MeSH Supplementary Concept]
- O19 antigen, xanthomonas maltophilia [MeSH Supplementary Concept]
- PCM 1207 lipopolysaccharide [MeSH Supplementary Concept]
- axinelloside A [MeSH Supplementary Concept]
- boivin antigen [MeSH Supplementary Concept]
- deacylated lipopolysaccharides [MeSH Supplementary Concept]
- defoslimod [MeSH Supplementary Concept]
- klebsiella O3 lipopolysaccharide [MeSH Supplementary Concept]
- lipid-linked oligosaccharides [MeSH Supplementary Concept]
- lipoarabinomannan [MeSH Supplementary Concept]
- lipomannan [MeSH Supplementary Concept]
- lipopolysaccharide A [MeSH Supplementary Concept]
- lipopolysaccharide B [MeSH Supplementary Concept]
- lipopolysaccharide I, yersinia pestis [MeSH Supplementary Concept]
- lipopolysaccharide II, yersinia pestis [MeSH Supplementary Concept]
- lipopolysaccharide IP-PA1, pantoea agglomerans [MeSH Supplementary Concept]
- lipopolysaccharide, E coli J5 [MeSH Supplementary Concept]
- lipopolysaccharide, E coli O55-B5 [MeSH Supplementary Concept]
- lipopolysaccharide, E. coli O26-B6 [MeSH Supplementary Concept]
- lipopolysaccharide, Escherichia coli O111 B4 [MeSH Supplementary Concept]
- lipopolysaccharide, helicobacter pylori [MeSH Supplementary Concept]
- lipopolysaccharide, helicobacter pylori serotype O2 [MeSH Supplementary Concept]
- lipopolysaccharide, proteus [MeSH Supplementary Concept]
- lipopolysaccharide-6A, yersinia pestis [MeSH Supplementary Concept]
- lipopolysaccharide-6B, yersinia pestis [MeSH Supplementary Concept]
- lipoteichoic acid [MeSH Supplementary Concept]
- monofucosyl A type 1 [MeSH Supplementary Concept]
- nod factor , azorhizobium caulinodans [MeSH Supplementary Concept]
- nod factor IV, bradyrhizobium japonicum [MeSH Supplementary Concept]
- nod factor IV, rhizobium meliloti [MeSH Supplementary Concept]
- nod factor V, bradyrhizobium japonicum [MeSH Supplementary Concept]
- nod factor, rhizobium etli [MeSH Supplementary Concept]
- nod factor, rhizobium giardinii [MeSH Supplementary Concept]
- nod factor, rhizobium leguminosarum [MeSH Supplementary Concept]
- pertussis endotoxin [MeSH Supplementary Concept]
- protollin [MeSH Supplementary Concept]
- pyrecol [MeSH Supplementary Concept]
- pyrifer [MeSH Supplementary Concept]
- pyrogenal [MeSH Supplementary Concept]
- re lipopolysaccharide [MeSH Supplementary Concept]
- serratigen [MeSH Supplementary Concept]
- serratimannan [MeSH Supplementary Concept]
- trinitrophenyl-lipopolysaccharide [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Lipopolysaccharide [NCIt concept]
- Lipopolysaccharide [FMA entity]
- Lipopolysaccharide (substance) [SNOMED CT concept]
- lipopolysaccharide, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients